Robert Spurr, U.S. President-Pharma Business at Bausch Health Companies Inc. (BHC), sold 6,502 shares at $25.02 ($163K) on 2022-02-15, disclosed to the SEC on 2022-02-17.
Open-market sale of $163k BHC by U.S. President-Pharma Business. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $25.02 | 3,251 | $81K | 50.0% |
| 2 | $25.02 | 3,251 | $81K | 50.0% |
| Total | $25.02 avg | 6,502 | $163K | 100% |
| Filing → |
| BHC | SELL | 2022-03-04 | $37K | — | Filing → |
| BHC | SELL | 2022-01-20 | $173K | — | Filing → |